http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#Head
http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#assertion
http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#provenance
http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#pubinfo
http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#assertion
http://purl.obolibrary.org/obo/DOID_14320
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_14320
http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB00285
http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#association
http://www.w3.org/2000/01/rdf-schema#label
venlafaxine hydrochloride extended release capsules usp are a serotonin and norepinephrine reuptake inhibitor snri indicated for the treatment of major depressive disorder mdd generalized anxiety disorder gad social anxiety disorder sad panic disorder pd venlafaxine hydrochloride extended release capsules usp are indicated for the treatment of major depressive disorder mdd efficacy was established in three short term 4 8 and 12 weeks and two long term maintenance trials venlafaxine hydrochloride extended release capsules usp are indicated for the treatment of generalized anxiety disorder gad efficacy was established in two 8 week and two 26 week placebo controlled trials venlafaxine hydrochloride extended release capsules usp are indicated for the treatment of social anxiety disorder sad also known as social phobia efficacy was established in four 12 week and one 26 week placebo controlled trials venlafaxine hydrochloride extended release capsules usp are indicated for the treatment of panic disorder pd with or without agoraphobia efficacy was established in two 12 week placebo controlled trials
http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#association
https://w3id.org/biolink/vocab/relation
https://schema.org/TreatmentIndication
https://identifiers.org/drugbank:DB00285
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#provenance
http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#pubinfo
http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#sig
http://purl.org/nanopub/x/hasSignature
jfJW9xt0gDKfNz7qNp/vO81l9cketKsri7eBSzpuz1bG3lUAUBc7fxebaQtPY0BuQIdlNqXnlUSB7fq+Cs/pzBvOZWg6ERQmSAfSYcgVqj9xpKX9LTK1Ln/k2nj+n9GxIKyrGeHw5rCxwyC+VMzrBGwXwHOAz4gro6uZsmrrni0=
http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE
http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE
http://purl.org/dc/terms/created
2021-06-29T08:11:52.392+02:00
http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs